| Cohort profile: the study of health in Pomerania H Völzke, D Alte, CO Schmidt, D Radke, R Lorbeer, N Friedrich, ... International journal of epidemiology 40 (2), 294-307, 2011 | 1147 | 2011 |
| United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) JM Löhr, E Dominguez-Munoz, J Rosendahl, M Besselink, J Mayerle, ... United European gastroenterology journal 5 (2), 153-199, 2017 | 577 | 2017 |
| IAP/APA evidence-based guidelines for the management of acute pancreatitis M Besselink, H van Santvoort, M Freeman, T Gardner, J Mayerle, ... Pancreatology 13 (4, suppl 2), E1-E15, 2013 | 539 | 2013 |
| European experts consensus statement on cystic tumours of the pancreas M Del Chiaro, C Verbeke, R Salvia, G Klöppel, J Werner, C McKay, ... Digestive and Liver Disease 45 (9), 703-711, 2013 | 506 | 2013 |
| A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis S Buch, F Stickel, E Trepo, M Way, A Herrmann, HD Nischalke, M Brosch, ... Nature genetics 47 (12), 1443-1448, 2015 | 445 | 2015 |
| Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study JW Valle, D Palmer, R Jackson, T Cox, JP Neoptolemos, P Ghaneh, ... Journal of clinical oncology 32 (6), 504-512, 2014 | 395 | 2014 |
| Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis DC Whitcomb, J LaRusch, AM Krasinskas, L Klei, JP Smith, RE Brand, ... Nature genetics 44 (12), 1349-1354, 2012 | 360 | 2012 |
| Chronic pancreatitis J Kleeff, DC Whitcomb, T Shimosegawa, I Esposito, MM Lerch, T Gress, ... Nature reviews Disease primers 3 (1), 1-18, 2017 | 346 | 2017 |
| Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey T Kamisawa, ST Chari, SA Giday, MH Kim, JB Chung, KT Lee, J Werner, ... Pancreas 40 (6), 809-814, 2011 | 321 | 2011 |
| Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes S Mueller, T Engleitner, R Maresch, M Zukowska, S Lange, ... Nature 554 (7690), 62-68, 2018 | 312 | 2018 |
| Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches M Orth, P Metzger, S Gerum, J Mayerle, G Schneider, C Belka, M Schnurr, ... Radiation Oncology 14 (1), 1-20, 2019 | 290 | 2019 |
| Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer A Aghdassi, M Sendler, A Guenther, J Mayerle, CO Behn, CD Heidecke, ... Gut 61 (3), 439-448, 2012 | 273 | 2012 |
| Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome) M Zenker, J Mayerle, MM Lerch, A Tagariello, K Zerres, PR Durie, M Beier, ... Nature genetics 37 (12), 1345-1350, 2005 | 272 | 2005 |
| Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial W Greenhalf, P Ghaneh, JP Neoptolemos, DH Palmer, TF Cox, RF Lamb, ... Journal of the National Cancer Institute 106 (1), djt347, 2014 | 269 | 2014 |
| Pancreatic pseudocysts: observation, endoscopic drainage, or resection? MM Lerch, A Stier, U Wahnschaffe, J Mayerle Deutsches Ärzteblatt International 106 (38), 614, 2009 | 264 | 2009 |
| Drug induced pancreatitis CJ Nitsche, N Jamieson, MM Lerch, JV Mayerle Best Practice & Research Clinical Gastroenterology 24 (2), 143-155, 2010 | 223 | 2010 |
| Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study ML Kromrey, R Bülow, J Hübner, C Paperlein, MM Lerch, T Ittermann, ... Gut 67 (1), 138-145, 2018 | 221 | 2018 |
| Diagnosis and treatment of pancreatic pseudocysts in chronic pancreatitis A Aghdassi, J Mayerle, M Kraft, AW Sielenkämper, CD Heidecke, ... Pancreas 36 (2), 105-112, 2008 | 210 | 2008 |
| Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis J Mayerle, H Kalthoff, R Reszka, B Kamlage, E Peter, B Schniewind, ... Gut 67 (1), 128-137, 2018 | 208 | 2018 |
| S3-guideline exocrine pancreatic cancer T Seufferlein, M Porzner, T Becker, V Budach, G Ceyhan, I Esposito, ... Zeitschrift fur Gastroenterologie 51 (12), 1395-1440, 2013 | 208 | 2013 |
